The specialty drug pipeline continues to accelerate, bringing transformative clinical advances alongside growing financial complexity. This webinar brings together pharmacy and stop loss consultants to examine how emerging therapies are reshaping treatment, utilization, and cost exposure across benefit programs.

This webinar will explore the expanding role of biosimilars, the rapidly growing pipeline of gene and cell therapies, and the evolving oncology treatment landscape. Designed for employers, this session will provide perspectives on balancing clinical innovation with financial risk, helping attendees anticipate challenges, identify opportunities, and align pharmacy management strategies with stop loss protection in an era of unprecedented specialty drug growth.